Clinical Features and Treatment Response in Stiff Person Spectrum Disorder: A Case Series from a Tertiary Neurology Centre
Objective: To describe the clinical features, electrophysiological findings, and treatment outcomes of patients with Stiff Person Spectrum Disorder (SPSD) evaluated at a tertiary neurology centre.…A case of ataxia and muscle stiffness in EEF2 gene mutation with associated anti-GAD antibodies
Objective: Here we present a case of ataxia and muscle stiffness in a person with variant EEF2 gene mutation with associated anti-GAD antibodies along with…GAD-Positive Versus GAD-Negative Stiff Person Syndrome: A Retrospective Study
Objective: Delineate demographic and clinical differences between GAD-65-antibody positive (seropositive) and negative (seronegative) SPS. Background: Elevated Glutamic Acid Decarboxylase 65 antibody (GAD-65 Ab) titers are…Anti-glutamic acid decarboxylase associated encephalitis presenting with new onset movement disorder after COVID-19 infection
Objective: To describe the unusual clinical manifestations in a patient with coronavirus disease 2019 (COVID-19). Background: Movement disorders are uncommon neurological manifestations of severe acute…Stiff person syndrome vs functional neurological disorder: two patients with hyperkinetic movement disorder
Objective: To describe two hyperkinetic disorders with manifestations that support the description of stiff-person syndrome Background: Stiff-person syndrome (SPS) is a rare condition with just…Unilateral Hypertrophic Olivary Degeneration in Anti-GAD-associated Encephalomyelitis
Objective: We present a patient with GAD65-Ab-related encephalomyelitis who developed unilateral hypertrophic olivary degeneration (HOD) in the absence of structural lesions within the Guillain-Mollaret triangle.…Immune-mediated movement disorder as a Rare Manifestation of a Sarcoma
Objective: We describe a rare case of a young woman with an immune-mediated movement disorder (paraneoplastic Stiff Person Syndrome) associated with a mediastinal liposarcoma. This…Outcomes of Gene therapy and Subsequent Deep Brain Stimulation for Parkinson’s Disease
Objective: The purpose of this study is to determine the outcomes of patients who received GAD gene therapy treatment and subsequently underwent DBS for Parkinson’s…GAD65 antibody neurologic syndrome presenting with hemiparkinsonism
Objective: To describe a novel phenotype of glutamic acid decarboxylase-65 (GAD65) antibody-associated neurological disease in which an older patient initially presented with levodopa-unresponsive hemiparkinsonism and…Association between Glutamic Acid Decarboxylase Antibodies (Anti-GADs) and Parkinsonism: Case Report
Objective: To make the first case report of the association between Anti-GAD and parkinsonism. Background: GAD (Glutamic Acid Decarboxylase) is the enzyme that catalyzes the synthesis of the…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.